The US Food and Drug Administration approved on Wednesday a Booster Dose of the Pfizer and BioNTech Covid-19 vaccine for those ages 65 and older. There are some high-risk Americans, paving the way for a quick rollout of the shots. The Booster Dose is to be administered at least six months after completion of the second dose.
The permission for the covid Booster Dose would include people most susceptible to severe disease and those in jobs that left them at risk. The agency said that the US Centers for Disease Control and Prevention advisory panel could vote on Thursday on the use of a third shot of the vaccine.Joe Biden announced in August that the intention of the government to launch booster shots for people ages 16 and older this week, pending approval by the FDA and CDC.
Many Advisers to the FDA voted on Friday to recommend Covid-19 vaccine booster shots for Americans 65 and older and those at high risk of severe illness, after overwhelmingly rejecting a call for broader approval. The advisory panel said there was not enough evidence to support booster shots for all those ages 16 and older who had received a second dose at least six months earlier and also sought more safety data.
Johnson & Johnson said on Tuesday the second shot of its Covid-19 vaccine increased its effectiveness in the United States against moderate to severe forms of the disease. Dr Anthony Fauci said on Sunday that the data from Moderna’s vaccine on Booster Dose is just weeks away.
Be First to Comment